Research-Grade Antipsychotic Compound Overview
Psyquit 25 mg is a pharmaceutical-grade quetiapine formulation manufactured by Cranialz specifically for advanced neurochemical research applications. Quetiapine is an atypical antipsychotic compound belonging to the dibenzothiazepine class, structurally distinct from conventional antipsychotic agents. This compound exhibits complex pharmacological properties through its interactions with multiple neurotransmitter receptor systems, making it a valuable tool for investigating dopaminergic, serotonergic, adrenergic, and histaminergic pathways in controlled laboratory environments. Researchers at Stroid UK Shop can access this pharmaceutical-grade material for comprehensive neuropharmacological studies examining receptor binding affinities and neurochemical modulation mechanisms.
Laboratory Investigation Applications
Research scientists utilise quetiapine compounds to examine the mechanistic basis of atypical antipsychotic activity across diverse experimental paradigms. The compound demonstrates high binding affinity for dopamine D2 receptors while exhibiting rapid dissociation kinetics, contributing to its unique pharmacological profile compared to conventional antipsychotics. Investigators study its interactions with serotonin 5-HT2A receptors, histamine H1 receptors, and adrenergic α1/α2 receptors to understand multi-target receptor modulation in neuropsychiatric research models. The quetiapine research category provides access to pharmaceutical-grade materials for studying metabolic pathways, receptor occupancy studies, and comparative pharmacokinetic analyses. Research applications extend to investigating selective receptor modulators and peptide interactions within complex neurochemical networks.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Quetiapine |
| Dosage Strength | 25 mg per tablet |
| Manufacturer | Cranialz |
| CAS Number | 111974-69-7 |
| Molecular Formula | C₂₁H₂₅N₃O₂S |
| Molecular Weight | 383.51 g/mol |
| Chemical Class | Dibenzothiazepine derivative |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Statement
Psyquit 25 mg quetiapine tablets are supplied exclusively for in-vitro laboratory research and analytical purposes. This pharmaceutical-grade material is intended solely for qualified research institutions and licensed laboratories conducting neurochemical investigations. The compound is not intended for human consumption, therapeutic applications, or any form of in-vivo administration. Researchers must comply with appropriate safety protocols and institutional guidelines when handling pharmaceutical research compounds. All experimental procedures should be conducted within properly equipped laboratory facilities with adequate ventilation and safety measures. This product is restricted to research use only and must not be used for any clinical, diagnostic, or therapeutic purposes.
